CID 11244661

N-(2,2-diethyl-4-oxo-thiazolidin-3-yl)-6-methyl-imidazo[2,1-b]thiazole-5-carboxamide

Structural Information

Molecular Formula
C14H18N4O2S2
SMILES
CCC1(N(C(=O)CS1)NC(=O)C2=C(N=C3N2C=CS3)C)CC
InChI
InChI=1S/C14H18N4O2S2/c1-4-14(5-2)18(10(19)8-22-14)16-12(20)11-9(3)15-13-17(11)6-7-21-13/h6-7H,4-5,8H2,1-3H3,(H,16,20)
InChIKey
YFOXYGHWHOLRNR-UHFFFAOYSA-N
Compound name
N-(2,2-diethyl-4-oxo-1,3-thiazolidin-3-yl)-6-methylimidazo[2,1-b][1,3]thiazole-5-carboxamide
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

1
References

0
Patents

338.08713 Da
Monoisotopic Mass

3.8
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 339.09441 174.8
[M+Na]+ 361.07635 186.5
[M-H]- 337.07985 180.5
[M+NH4]+ 356.12095 194.4
[M+K]+ 377.05029 182.8
[M+H-H2O]+ 321.08439 170.7
[M+HCOO]- 383.08533 187.1
[M+CH3COO]- 397.10098 186.6
[M+Na-2H]- 359.06180 171.7
[M]+ 338.08658 182.0
[M]- 338.08768 182.0
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

No patent data available for this compound.